Home › NCT07682610
Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Health Services Research Intervention
Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System (Kentucky QUILS™ Implementation): HSR Intervention
Who can join
Ages 18 to 100 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Member of a participating Lung Cancer Screening Program (LCSP) team or administrator * Willing to participate in the QUILS Index Assessment Survey process * Willing to participate in the QUILS Audit Feedback presentations * Willing to participate in formative evaluation interviews Exclusion Criteria: * Unwilling to participate in the QUILS Index Assessment Survey process * Unwilling to participate in the QUILS Audit Feedback presentations * Unwilling to participate in formative evaluation interviews
About the study
This clinical trial studies statewide optimization of lung cancer screening (LCS) in Kentucky using the Quality Implementation of Lung Screening (QUILS™) System. Data from the Kentucky Cancer Registry shows that LCS implementation has contributed to a rapid decline in late-stage lung cancer diagnosis at twice the national average. Further, the declines are more than three times the national average decline in Kentucky's Central Appalachian region. Kentucky-based multilevel initiatives are needed to expand and accelerate this leading role and extend the LCS opportunity to more Kentuckians who are at increased risk of lung cancer. This trial may be able to accelerate optimal high-quality implementation of LCS utilizing the QUILS™ System and reduce the burden of lung cancer by assisting lung cancer screening programs located throughout Kentucky in implementing best practices in lung cancer screening by integrating the QUILS™ System domains and elements into their screening programs.
What is being tested
- Quality Implementation of Lung Cancer Screening (QUILS) System (behavioral)
Sponsor: Timothy Mullett · Participants: 35,500 · Started: Apr 1, 2025
Contact the study team
- Joseph Alexander, MD · Phone: 8593230892
Official record on ClinicalTrials.gov — NCT07682610
Locations in the U.S.
| Kentucky | King's Daughter's Medical Center, Ashland Taylor Regional Hospital, Campbellsville St. Elizabeth Healthcare, Edgewood Georgetown Cancer Treatment Cancer, Georgetown TJ Samson Community Hospital, Glasgow Hazard Appalachian Regional Healthcare Medical Center, Hazard Lexington VA Health Care System, Lexington St. Joseph Health (Catholic Health Initiatives), Lexington University of Kentucky Markey Cancer Center, Lexington The James Graham Brown Cancer Center at University of Louisville, Louisville Meadowview Regional Medical Center, Maysville Saint Claire Regional Medical Center, Morehead Rockcastle Regional Hospital, Mount Vernon Owensboro Health Mitchell Memorial Cancer Center, Owensboro Mercy Health - Paducah Cancer Center, Paducah Lake Cumberland Regional Hospital, Somerset Clark Regional Medical Center, Winchester |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.